Gamida Cell’s proprietary nicotinamide (NAM) technology is a culture method that helps deliver cell therapies with enhanced functionality, leading to better clinical outcomes. Their allogenic therapies include stem cells with improved homing and retention as well as natural killer (NK) cells with increased resistance to oxidative stress.